Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · March 28, 2023

SGLT2 Inhibitors and Cancer Outcomes

Diabetes Research and Clinical Practice


Additional Info

Disclosure statements are available on the authors' profiles:

Diabetes Research and Clinical Practice
Sodium-Glucose Cotransporter-2 inhibitors and Cancer Outcomes: a systematic review and meta-analysis of randomized controlled trials
Diabetes Res. Clin. Pract. 2023 Mar 13;[EPub Ahead of Print], BF Spiazzi, RA Naibo, LF Wayerbacher, GF Piccoli, LP Farenzena, TM Londero, GR da Natividade, M Zoldan, N A H Degobi, M Niches, G Lopes, EJ Boyko, KM Utzschneider, V Colpani, F Gerchman

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading